Myoungil Cha - 15 Jun 2022 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
Rachel Malina, Attorney-in-Fact for Myoungil Cha
Issuer symbol
TNDM
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 18:46:48 UTC
Next filing
26 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Award $0 +5,247 $0.000000 5,247 15 Jun 2022 Common Stock 5,247 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded on June 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F2 Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F3 The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.